167 related articles for article (PubMed ID: 21352822)
1. Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: effect of inflammatory cytokines.
Pankajakshan D; Jia G; Pipinos I; Tyndall SH; Agrawal DK
Exp Mol Pathol; 2011 Jun; 90(3):280-6. PubMed ID: 21352822
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: effect of IL-12 and IFN-gamma.
Jia G; Cheng G; Soundararajan K; Agrawal DK
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1051-7. PubMed ID: 17040964
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
5. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis.
Rao VH; Rai V; Stoupa S; Subramanian S; Agrawal DK
Atherosclerosis; 2016 May; 248():160-9. PubMed ID: 27017522
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
8. Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.
Rao VH; Rai V; Stoupa S; Agrawal DK
Am J Physiol Heart Circ Physiol; 2015 Sep; 309(6):H1075-86. PubMed ID: 26254334
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Fisher TA; Ji H
Regul Pept; 1998 Sep; 75-76():231-8. PubMed ID: 9802414
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
Ammar DA; Hughes BA; Thompson DA
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy.
Yoon HZ; Yan Y; Geng Y; Higgins RD
Clin Exp Ophthalmol; 2002 Dec; 30(6):424-9. PubMed ID: 12427234
[TBL] [Abstract][Full Text] [Related]
13. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
Widdowson PS
Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery.
Li L; Lee EW; Ji H; Zukowska Z
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1204-10. PubMed ID: 12689918
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.
Edsfeldt A; Dunér P; Ståhlman M; Mollet IG; Asciutto G; Grufman H; Nitulescu M; Persson AF; Fisher RM; Melander O; Orho-Melander M; Borén J; Nilsson J; Gonçalves I
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1132-40. PubMed ID: 27055903
[TBL] [Abstract][Full Text] [Related]
16. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.
Malmström RE; Hökfelt T; Björkman JA; Nihlén C; Byström M; Ekstrand AJ; Lundberg JM
Regul Pept; 1998 Sep; 75-76():55-70. PubMed ID: 9802394
[TBL] [Abstract][Full Text] [Related]
17. A Y2 receptor mimetic aptamer directed against neuropeptide Y.
Proske D; Höfliger M; Söll RM; Beck-Sickinger AG; Famulok M
J Biol Chem; 2002 Mar; 277(13):11416-22. PubMed ID: 11756401
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity.
Nie M; Selbie LA
Regul Pept; 1998 Sep; 75-76():207-13. PubMed ID: 9802411
[TBL] [Abstract][Full Text] [Related]
19. Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors.
Li L; Jönsson-Rylander AC; Abe K; Zukowska Z
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2075-80. PubMed ID: 16051880
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
